Fluoroolefin Dipeptide Isosteres: Structure, Syntheses, and Applications

Fluorine and Health

Volumn , Issue , 2008, Pages 699-735

  Welch, John T ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349180079     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-444-53086-8.00016-3     Document Type: Chapter

References (106)

1. Gante J. Peptide mimetics-tailor-made enzyme inhibitors. Angew. Chem. Int. Ed. 1994, 33:1699-1720.
2. Ahn J.M., Boyle N.A., MacDonald M.T., Janda K.D. Peptidomimetics and peptide backbone modifications. Mini Rev. Med. Chem. 2002, 2:463-473.
3. Penke B., Toth G., Varadi G. Analogue and conformational studies on peptides, hormones and other biologically active peptides. Amino Acids Pept. Proteins 2003, 34:55-148.
4. West M.L., Fairlie D. Targeting HIV-1 protease: A test of drug-design methodologies. Trends Pharmacol. Sci. 1995, 16:67-74.
5. Gillespie P., Cicariello J., Olson G.L. Conformational analysis of dipeptide mimetics. Biopolymers 1997, 43:191-217.
6. Spatola A.F. Peptide backbone modifications: A structure-activity analysis of peptides containing amide bond surrogates, conformational constraints, and related backbone replacements. Chemistry and Biochemistry of Amino Acids, Peptides and Proteins 1983, 267-357. Marcel Dekker, New York. B. Weinstein (Ed.).
7. Vasbinder M.M., Miller S.J. Synthesis of the Pro-Gly dipeptide alkene isostere using olefin cross-metathesis. J. Org. Chem. 2002, 67:6240-6242.
8. Dugave C., Demange L. Cis-trans isomerization of organic molecules and biomolecules: Implications and applications. Chem. Rev. (Washington, DC, United States) 2003, 103:2475-2532.
9. Hann M.M., Sammes P.G., Kennewell P.D., Taylor J.B. On double bond isosteres of the peptide bond; an enkephalin analog. J. Chem. Soc. Chem. Commun. 1980, 234-235.
10. Hann M.M., Sammes P.G., Kennewell P.D., Taylor J.B. On the double bond isostere of the peptide bond: Preparation of an enkephalin analog. J. Chem. Soc. Perkin Trans. 1982, 1:307-314.
11. Fujimoto K., Doi R., Hosotani R., Wada M., Lee J.-U., Koshiba T., Ibuka T., Habashita H., Nakai K., Fujii N., Imamura M. Effects of structural modulation on biological activity of bombesin analogues with (E)-alkene bond. Life Sci. 1997, 60:29-34.
12. Miyasaka K., Kanai S., Masuda M., Ibuka T., Nakai K., Fujii N., Funakoshi A. Involvement of cholinergic processes in cholecystokinin (CCK) release [corrected] by luminal oleic acid. J. Auton. Nerv. Syst. 1997, 63:179-182.
13. Christos T.E., Arvanitis A., Cain G.A., Johnson A.L., Potorf R.S., Tam S.W., Schmidt W.K. Stable isosteres of neurotensin C-terminal pentapeptides derived by modification of the amide function. Bioorg. Med. Chem. Lett. 1993, 3:1035-1040.
14. Bartlett P.A., Otake A. Fluoroalkenes as peptide isosteres: Ground state analog inhibitors of thermolysin. J. Org. Chem. 1995, 60:3107-3111.
15. Wai J.S., Bamberger D.L., Fisher T.E., Graham S.L., Smith R.L., Gibbs J.B., Mosser S.D., Oliff A.I., Pompliano D.L., Rands E., Kohl N.E. Synthesis and biological activity of Ras farnesyl protein transferase inhibitors. Tetrapeptide analogs with amino methyl and carbon linkages. Bioorg. Med. Chem. 1994, 2:939-947.
16. Dugave C. Study of the cis-trans isomerization of the amino-acyl prolyl peptide bond. Application to the design of novel inhibitors of immunophilins. Curr. Org. Chem. 2002, 6:1397-1431.
17. Bandur N.G., Harms K., Koert U. First stereoselective synthesis of a Pro-Pro E-alkene dipeptide isostere. Synlett 2005, 773-776.
18. N2′ reactions. J. Org. Chem. 2002, 67:6152-6161.
19. Sasaki Y., Niida A., Tsuji T., Shigenaga A., Fujii N., Otaka A. Stereoselective synthesis of (Z)-alkene-containing proline dipeptide mimetics. J. Org. Chem. 2006, 71:4969-4979.
20. Hart S.A., Sabat M., Etzkorn F.A. Enantio- and regioselective synthesis of a (Z)-alkene cis-proline mimic. J. Org. Chem. 1998, 63:7580-7581.
21. Wang X.J., Etzkorn F.A. Peptidyl-prolyl isomerase inhibitors. Biopolymers 2006, 84:125-146.
22. Wang X.J., Hart S.A., Xu B., Mason M.D., Goodell J.R., Etzkorn F.A. Serine-cis-proline and Serine-trans-proline isosteres: Stereoselective synthesis of (Z)- and (E)-alkene mimics by still-wittig and ireland-claisen rearrangements. J. Org. Chem. 2003, 68:2343-2349.
23. Hart S.A. (Z)- and (E)-alkene cis- and trans-proline isosteres as mimics of cyclophilin and pin1 substrates 2001, University of Virginia, Ph.D. Dissertation.
24. Etzkorn F.A. Protein mimics inhibit enzymes that regulate the cell cycle 2004, Abstracts of papers 228th ACS National meeting, Aug. 22-26.
25. Cheng C.Y., Liou B.I., Jih S.T. Stereoselective synthesis of trans-(E)-N-{2-[4-(3,4-dichlorophenyl)but-2-en-2-yl]cyclohexyl}pyrrolidi ne as an alkene mimetic of the arylacetamide analgesics. J. Chinese Chem. Soc. (Taipei, Taiwan) 1993, 40:67-71.
26. Oishi S., Kamano T., Niida A., Odagaki Y., Hamanaka N., Yamamoto M., Ajito K., Tamamura H., Otaka A., Fujii N. Diastereoselective synthesis of new y[(E)-CH=CMe]- and Ψ[(Z)-CH=CMe]-type alkene dipeptide isosteres by organocopper reagents and application to conformationally restricted cyclic RGD peptidomimetics. J. Org. Chem. 2002, 67:6162-6173.
27. Oishi S., Miyamoto K., Niida A., Yamamoto M., Ajito K., Tamamura H., Otaka A., Kuroda Y., Asai A., Fujii N. Application of tri- and tetrasubstituted alkene dipeptide mimetics to conformational studies of cyclic RGD peptides. Tetrahedron 2006, 62:1416-1424.
28. Fujii N., Nakai K., Habashita H., Otaka A., Ibuka T., Wada M., Doi R., Hosotani R., Imamura M. Highly stereoselective synthesis of (E)-alkene dipeptide isosteres via organocopper mediated 1,3-chirality transfer reaction and its application to the synthesis of a potent bombesin antagonist with no agonistic activity in Peptides 1994 1995.
29. Garbe D., Sieber S.A., Bandur N.G., Koert U., Marahiel M.A. Enzymatic cyclization of peptidomimetics with incorporated (E)-alkene dipeptide isosteres. ChemBioChem 2004, 5:1000-1003.
30. Cox M.T., Heaton D.W., Horbury J. Preparation of protected trans-olefinic dipeptide isosteres. J. Chem. Soc. Chem. Commun. 1980, 799-800.
31. Johnson R.L. Inhibition of renin by substrate analogue inhibitors containing the olefinic amino acid 5(S)-amino-7-methyl-3(E)-octenoic acid. J. Med. Chem. 1984, 27:1351-1354.
32. Beresis R., Panek J.S. A concise enantioselective synthesis of trans-olefin dipeptide isosteres. Bioorg. Med. Chem. Lett. 1993, 3:1609-1614.
33. Spaltenstein A., Carpino P.A., Miyake F., Hopkins P.B. A stereocontrolled synthesis of trans-alkene isosteres of dipeptides. Tetrahedron Lett. 1986, 27:2095-2098.
34. Charrier C., Ettouati L., Paris J. New application of the Julia olefination for the synthesis of Tyr-Gly E-alkene and carba isostere pseudopeptides. Tetrahedron Lett. 1999, 40:5705-5707.
35. Henninger T.C., Wipf P. (E)-Alkene peptide bond isosteres by cuprate opening of vinyl aziridines. Methods Mol. Med. 1999, 23:125-136.
36. Wipf P., Henninger T.C. Solid-phase synthesis of peptide mimetics with (E)-alkene amide bond replacements derived from alkenylaziridines. J. Org. Chem. 1997, 62:1586-1587.
37. Ellison S.L. 1984, University of Liverpool, Ph.D. Dissertation.
38. Schlosser M. The Chemical and Physiological Size of Fluorine in Enantiocontrolled Synthesis of Fluoro-Organic Compounds 1999, 613-659. John Wiley & Sons Ltd., Chichester. V.A. Soloshonok (Ed.).
39. Jaeckel C., Koksch B. Fluorine in peptide design and protein engineering. Eur. J. Org. Chem. 2005, 4483-4503.
40. Welch J.T., Jeong I.H., Chung W.J., Zhao K., Lin J. Fluorination and electrostatic interactions in enzyme binding, Fluorinated Bio-active Compounds 1999.
41. Xiao J., Weisblum B., Wipf P. Electrostatic versus steric effects in peptidomimicry: Synthesis and secondary structure analysis of gramicidin S analogues with (E)-alkene peptide isosteres. J. Am. Chem. Soc. 2005, 127:5742-5743.
42. Abraham R.J., Ellison S.L.R., Schonholzer P., Thomas W.A. A theoretical and crystallographic study of the geometries and conformations of fluoro-olefins as peptide analogs. Tetrahedron 1986, 42:2101-2110.
43. Cieplak P., Kollman P.A. Peptide mimetics as enzyme inhibitors: Use of free energy perturbation calculations to evaluate isosteric replacement for amide bonds in a potent HIV protease inhibitor. J. Comput. Aided Mol. Des. 1993, 7:291-304.
44. Boros L.G., Corte B.D., Gimi R.H., Welch J.T., Wu Y., Handschumacher R.E. Fluoroolefin peptide isosteres-tools for controlling peptide conformations. Tetrahedron Lett. 1994, 35:6033-6036.
45. Welch J.T., Allmendinger T. Fluoroolefin isosteres. Methods Mol. Med. 1999, 23:357-384.
46. Allmendinger T., Furet P., Hungerbuehler E. Fluoroolefin dipeptide isosteres. I. The synthesis of Glyy[CF=CH]Gly and racemic Phey[CF=CH]Gly. Tetrahedron Lett. 1990, 31:7297-7300.
47. Allmendinger T., Felder E., Hungerbuehler E. Fluoroolefin dipeptide isosteres. II. Enantioselective synthesis of both antipodes of the Phe-Gly dipeptide mimic. Tetrahedron Lett. 1990, 31:7301-7304.
48. Dehmlow E.V., Franke K. Uses of phase transfer catalysis. 11. Phase transfer catalytic reactions of heterocycles with dihalocarbenes. Liebigs Ann. der Chemie 1979, 1456-1464.
49. Laue K.W., Muck-Lichtenfeld C., Haufe G. Enantioselective syntheses of 2-amino-4-fluoropent-4-enoic acids. Isosteres of asparagine. Tetrahedron 1999, 55:10413-10424.
50. Shendage D.M., Froehlich R., Bergander K., Haufe G. Asymmetric synthesis of γ-fluorinated α-amino acid derivatives. Eur. J. Org. Chem. 2005, 719-727.
51. 3. Bull. Chem. Soc. Japan 2000, 73:1685-1690.
52. Saito A., Nakagawa M., Taguchi T. Chromium-mediated fluoroalkenylation reactions of 1,1-dibromo-1-fluoroalkane and 1-bromo-1-fluoroalkene derivatives. J. Fluor. Chem. 2005, 126:1166-1173.
53. Dutheuil G., Lei X., Pannecoucke X., Quirion J.C. A novel diastereoselective synthesis of (Z)-fluoroalkenes via a Nozaki-Hiyama-Kishi-Type reaction. J. Org. Chem. 2005, 70:1911-1914.
54. Dutheuil G., Paturel C., Lei X., Couve-Bonnaire S., Pannecoucke X. First stereospecific synthesis of (E)- or (Z)-a-fluoroenones via a kinetically controlled negishi coupling reaction. J. Org. Chem. 2006, 71:4316-4319.
55. Veenstra S.J., Hauser K., Felber P. Studies on the active conformation of the NK1 antagonist CGP 49823. Part 2. Fluoro-olefin analogs of tertiary amide rotamers. Bioorg. Med. Chem. Lett. 1997, 7:351-354.
56. Pfund E., Masson S., Vazeux M., Lequeux T. Syntheses of α-fluoroα,β-unsaturated thioamides and thiazolines from a fluorophosphonodithioacetate. J. Org. Chem. 2004, 69:4670-4676.
57. Allmendinger T., Fujimoto R., Gasparini F., Schilling W., Satoh Y. α-Fluoro-benzylphosphonates as reagents for the preparation of 1-fluoro-1-aryl alkenes and α-fluorostilbenes. Chimia 2004, 58:133-137.
58. Sano S., Teranishi R., Nagao Y. Toward (Z)-selective Horner-Wadsworth-Emmons reaction of aldehydes with 2-fluoro-2-diethylphosphonoacetic acid. Tetrahedron Lett. 2002, 43:9183-9186.
59. Sano S., Saito K., Nagao Y. Tandem reduction-olefination for the stereoselective synthesis of (Z)α-fluoroα,β-unsaturated esters. Tetrahedron Lett. 2003, 44:3987-3990.
60. Van der Veken P., Kertesz I., Senten K., Haemers A., Augustyns K. Synthesis of (E)- and (Z)-fluoro-olefin analogs of potent dipeptidyl peptidase IV inhibitors. Tetrahedron Lett. 2003, 44:6231-6234.
61. Van der Veken P., Senten K., Kertesz I., De Meester I., Lambeir A.M., Maes M.B., Scharpe S., Haemers A., Augustyns K. Fluoro-olefins as peptidomimetic inhibitors of dipeptidyl peptidases. J. Med. Chem. 2005, 48:1768-1780.
62. van Steenis J.H., Van den Nieuwendijk A.M.C.H., van der Gen A. α-fluoroacrylonitriles: Horner-Wittig synthesis and conversion into 2-fluoroallylamines and C-(1-fluorovinyl)nitrones. J. Fluor. Chem. 2004, 125:107-117.
63. Lin J., Toscano P.J., Welch J.T. Inhibition of dipeptidyl peptidase IV by fluoroolefin-containing N-peptidyl-O-hydroxylamine peptidomimetics. Proc. Natl. Acad. Sci. USA 1998, 95:14020-14024.
64. Welch J.T., Lin J. Fluoroolefin containing dipeptide isosteres as inhibitors of dipeptidyl peptidase IV(CD26). Tetrahedron 1996, 52:291-304.
65. Zhao K., Lim D.S., Funaki T., Welch J.T. Inhibition of dipeptidyl peptidase IV (DPP IV) by 2-(2-amino-1-fluoro-propylidene)-cyclopentanecarbonitrile, a fluoroolefin containing peptidomimetic. Bioorg. Med. Chem. 2003, 11:207-215.
66. Otaka A., Mitsuyama E., Watanabe J., Watanabe H., Fujii N. Synthesis of fluorine-containing bioisosteres corresponding to phosphoamino acids and dipeptide units. Biopolymers 2004, 76:140-149.
67. Okada M., Nakamura Y., Saito A., Sato A., Horikawa H., Taguchi T. Stereoselective construction of functionalized (Z)-fluoroalkenes directed to depsipeptide isosteres. Tetrahedron Lett. 2002, 43:5845-5847.
68. Nakamura Y., Okada M., Horikawa H., Taguchi T. Preparation of δ-fluorinated homoallylic alcohol derivatives via regioselective hydride reduction of allylic alcohol derivatives. J. Fluor. Chem. 2002, 117:143-148.
69. Otaka A., Watanabe H., Yukimasa A., Oishi S., Tamamura H., Fujii N. New access to α-substituted (Z)-fluoroalkene dipeptide isosteres utilizing organocopper reagents under 'reduction-oxidative alkylation (R-OA)' conditions. Tetrahedron Lett. 2001, 42:5443-5446.
70. Otaka A., Watanabe H., Mitsuyama E., Yukimasa A., Tamamura H., Fujii N. Synthesis of (Z)-fluoroalkene dipeptide isosteres utilizing organocopper-mediated reduction of γ,γ-difluoroα,β-enoates. Tetrahedron Lett. 2001, 42:285-287.
71. 2CuLi. Chem. Lett. 2002, 28-29.
72. Nakamura Y., Okada M., Sato A., Horikawa H., Koura M., Saito A., Taguchi T. Stereoselective synthesis of (Z)-fluoroalkenes directed to peptide isosteres: Copper mediated reaction of trialkylaluminum with 4,4-difluoro-5-hydroxyallylic alcohol derivatives. Tetrahedron 2005, 61:5741-5753.
73. 2-mediated reduction of γ,γ-difluoroα,β-enoates with application to the synthesis of functionalized (Z)-fluoroalkene-type dipeptide isosteres. J. Org. Chem. 2004, 69:1634-1645.
74. Niida A., Mizumoto M., Narumi T., Inokuchi E., Oishi S., Ohno H., Otaka A., Kitaura K., Fujii N. Synthesis of (Z)-alkene and (E)-fluoroalkene-containing diketopiperazine mimetics utilizing organocopper-mediated reduction-alkylation and diastereoselectivity examination using DFT calculations. J. Org. Chem. 2006, 71:4118-4129.
75. Hata H., Kobayashi T., Amii H., Uneyama K., Welch J.T. A new sequential defluorination route to α-fluoroα,β-unsaturated ketones from trifluoromethyl ketones. Tetrahedron Lett. 2002, 43:6099-6102.
76. Chen C., Wilcoxen K., Huang C.Q., Strack N., McCarthy J.R. New methods for the synthesis of fluoro olefins via the palladium catalyzed cross-coupling reaction of 1-fluorovinyl halides with organoboranes and organostannanes. J. Fluor. Chem. 2000, 101:285-290.
77. Ernet T., Haufe G. Allylic hydroxylation of vinyl fluorides. Synthesis 1997, 953-956.
78. Essers M., Mück-Lichtenfeld C., Haufe G. Diastereoselective diels-alder reactions of α-Fluorinated α ,β-unsaturated carbonyl compounds: Chemical consequences of fluorine substitution. J. Org. Chem. 2002, 67:4715-4721.
79. Bainbridge J.M., Corr S., Kanai M., Percy J.M. HFC-134a as a fluorinated building block: Short synthesis of a-fluoro enones. Tetrahedron Lett. 2000, 41:971-974.
80. Watts R.O., Allison C.G., Barthold K.P., Tarrant P. Reaction of hexafluoropropene oxide with Grignard reagents. J. Fluor. Chem. 1973, 3:7-15.
81. Funabiki K., Kurita T., Matsui M., Shibata K. An efficient and general entry to (Z)α-fluoroβ-substituted acrylaldehydes based on the coupling reaction of α-fluoroβ-amino acrylaldehydes with organolithium reagents. Chem. Lett. 1997, 739-740.
82. Andrès D.F., Dietrich U., Laurent E.G., Marquet B.S. Anodic fluorination of vinyl sulfides - synthesis of α-fluoroβ-thioα,β-unsaturated carbonyl compounds. Tetrahedron 1997, 53:647-658.
83. Marhold M., Buer A., Hiemstra H., van Maarseveen J.H., Haufe G. Synthesis of vinyl fluorides by ring-closing metathesis. Tetrahedron Lett. 2004, 45:57-60.
84. Salim S.S., Bellingham R.K., Satcharoen V., Brown R.C.D. Synthesis of heterocyclic and carbocyclic fluoro-olefins by ring-closing metathesis. Org. Lett. 2003, 5:3403-3406.
85. Eberhardt E.S., Raines R.T. Amide-amide and amide-water hydrogen bonds: Implications for protein folding and stability. J. Am. Chem. Soc. 1994, 116:2149-2150.
86. Fischer G. Enzymes that catalyse the restructuring of proteins. Curr. Opin. Struct. Biol. 2000, 10:40-45.
87. Welch J.T. Bond strengths and reactivity in organo-fluorine compounds. Houben Weyl Methoden der Organische Chemie, E10b Part 2 Fluorine 1999, 293-305. Georg Thieme Verlag, Stuttgart. B. Baasner (Ed.).
88. Smart B.E. Fluorine substituent effects (on bioactivity). J. Fluor. Chem. 2001, 109:3-11.
89. Biffiner J.C., Kim H.W., DiMagno S.G. The polar hydrophobicity of fluorinated compounds. ChemBioChem 2004, 5:622-627.
90. Etzkorn F.A., Stolz L.A., Chang Z.Y., Walsh C.T. Role of the cyclosporin-A-cyclophilin complex, FK506-FK506-binding protein complex and calcineurin in the inhibition of T-cell signal transduction. Curr. Opin. Struct. Biol. 1993, 3:929-933.
91. Gothel S.F., Marahiel M.A. Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts. Cell. Mol. Life Sci. 1999, 55:423-436.
92. Joseph J.D., Yeh E.S., Swenson K.I., Means A.R. The peptidyl-prolyl isomerase Pin1. Prog. Cell Cycle Res. 2003, 5:477-487.
93. Li Q., Moutiez M., Charbonnier J.B., Vaudry K., Menez A., Quemeneur E., Dugave C. Design of a gag pentapeptide analogue that binds human cyclophilin a more efficiently than the entire capsid protein: New insights for the development of novel anti-HIV-1 drugs. J. Med. Chem. 2000, 43:1770-1779.
94. Demange L., Moutiez M., Vaudry K., Dugave C. Interaction of human cyclophilin hCyp-18 with short peptides suggests the existence of two functionally independent subsites. FEBS Lett. 2001, 505:191-195.
95. Wang H.C., Kim K., Bakhtiar R., Germanas J.P. Structure-activity studies of ground- and transition-state analogue inhibitors of cyclophilin. J. Med. Chem. 2001, 44:2593-2600.
96. Zhang Y. Inhibitors targeting the enzymatic activity and biological function of Pin1. Mini Rev. Org. Chem. 2004, 1:359-366.
97. Lambeir A.M., Durinx C., Scharpe S., De Meester I. Dipeptidyl-peptidase IV from bench to bedside: An update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit. Rev. Clin. Lab. Sci. 2003, 40:209-294.
98. Augustyns K., Van der Veken P., Haemers A. Inhibitors of proline-specific dipeptidyl peptidases: DPP IV inhibitors as a novel approach for the treatment of Type 2 diabetes. Expert Opin. Ther. Patents 2005, 15:1387-1407.
99. Wiedeman P.E., Trevillyan J.M. Dipeptidyl peptidase IV inhibitors for the treatment of impaired glucose tolerance and type 2 diabetes. Curr. Opin. Investig. Drugs (Thomson Curr. Drugs) 2003, 4:412-420.
100. Weber A.E. Dipeptidyl Peptidase IV Inhibitors for the Treatment of Diabetes. J. Med. Chem. 2004, 47:4135-4141.
101. Augustyns K., Van der Veken P., Senten K., Haemers A. The therapeutic potential of inhibitors of dipeptidyl peptidase IV (DPP IV) and related proline-specific dipeptidyl aminopeptidases. Curr. Med. Chem. 2005, 12:971-998.
102. Augustyns K., Van der Veken P., Senten K., Haemers A. Dipeptidyl peptidase IV inhibitors as new therapeutic agents for the treatment of type 2 diabetes. Expert Opin. Ther. Patents 2003, 13:499-510.
103. Engel M., Hoffmann T., Wagner L., Wermann M., Heiser U., Kiefersauer R., Huber R., Bode W., Demuth H.U., Brandstetter H. The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism. Proc. Natl. Acad. Sci. USA 2003, 100:5063-5068.
104. Chiravuri M., Schmitz T., Yardley K., Underwood R., Dayal Y., Huber B.T. A novel apoptotic pathway in quiescent lymphocytes identified by inhibition of a post-proline cleaving aminodipeptidase: A candidate target protease, quiescent cell proline dipeptidase. J. Immunol. 1999, 163:3092-3099.
105. Loughlin W.A., Tyndall J.D.A., Glenn M.P., Fairlie D.P. Beta-Strand Mimetics. Chem. Rev. (Washington, DC, United States) 2004, 104:6085-6117.
106. Etzkorn F.A., Travins J.M., Hart S.A. Rare protein turns: γ-turn, helix-turn-helix, and cis-proline mimics. Adv. Amino Acid Mimet. Peptidomimet. 1999, 2:125-163.